Biochemical Characterization of Glutamate Racemase-A New Candidate Drug Target against Burkholderia cenocepacia Infections.
The greatest obstacle for the treatment of cystic fibrosis patients infected with the Burkholderia species is their intrinsic antibiotic resistance. For this reason, there is a need to develop new effective compounds. Glutamate racemase, an essential enzyme for the biosynthesis of the bacterial cell...
Main Authors: | Aygun Israyilova, Silvia Buroni, Federico Forneris, Viola Camilla Scoffone, Namiq Q Shixaliyev, Giovanna Riccardi, Laurent Roberto Chiarelli |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5127577?pdf=render |
Similar Items
-
Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches
by: Viola C. Scoffone, et al.
Published: (2017-08-01) -
Investigating the Mechanism of Action of Diketopiperazines Inhibitors of the Burkholderia cenocepacia Quorum Sensing Synthase CepI: A Site-Directed Mutagenesis Study
by: Silvia Buroni, et al.
Published: (2018-07-01) -
Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia
by: Laurent R. Chiarelli, et al.
Published: (2020-04-01) -
Molecular Characterization of the <i>Burkholderia cenocepacia</i> <i>dcw</i> Operon and FtsZ Interactors as New Targets for Novel Antimicrobial Design
by: Gabriele Trespidi, et al.
Published: (2020-11-01) -
Efflux-mediated resistance to a benzothiadiazol derivative effective against Burkholderia cenocepacia
by: Viola Camilla eScoffone, et al.
Published: (2015-08-01)